Newsquawk Logo

Hims & Hers (HIMS) says it will sell a copy of Novo's (NOVOB DC) Wegovy pill at USD 49/mnth

Hims & Hers' announcement to sell a copy of Novo's Wegovy pill at $49/month signals potential disruption in the weight management market.

Newsquawk StaffPublished On the live feed at — 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Revelio Labs says US Jan Non-farm Jobs -13.3k M/M (prev. +71k in December)

BofA Consumer Checkpoint: W/e January 31st total card spending -3.2% Y/Y (vs. prior week +6.6% Y/Y) and the slowdown was most likely due to Winter Storm Fern

Hims & Hers (HIMS) says it will sell a copy of Novo's (NOVOB DC) Wegovy pill at USD 49/mnth

Czech CNB Interest Rate Decision 3.50% vs. Exp. 3.5% (Prev. 3.50%, Rev. From 3.5%)

US Continuing Jobless Claims (Jan/24) 1,844K vs. Exp. 1,850K (Prev. 1,819K, Rev. From 1,827K)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

This move positions Hims to leverage the growing demand for accessible weight loss solutions, which might attract interest from consumers looking for affordable options. Investors should watch for competitive responses from both Novo Nordisk and other players in the healthcare space, as this could reshape pricing strategies moving forward.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.